Politics Lilly, Novo bet on amylin obesity drugs after GLP-1s Finance News Oct 2, 2026 The next generation of blockbuster obesity drugs isn't trying to replace GLP-1 medicines.Instead, drugmakers are… Read More...
Business Eli Lilly obesity drug with amylin, tirzepatide boosts weight loss in trial Finance News Sep 30, 2026 Eli Lilly on Wednesday said its experimental combination regimen resulted in greater weight loss than a high dose of… Read More...
